However, the history of PCSK9 is still evolving, and this study could represent a road map for further investigations in the IBD population aimed to evaluate the role of PCSK9 not only as a biomarker of disease activity but also for cardiovascular risk, together with its therapeutic application for cardiovascular risk reduction. The gene discussed is PCSK9; the disease is inflammatory bowel disease.